Pharmacology Approach Pulmonary Hypertension in Mechanical Ventilated Critical Care Patients
A Special Issue of Journal of Cardiovascular Development and Disease (ISSN 2308-3425) belonging to the section "Cardiovascular Clinical Research".
Deadline for manuscript submissions: 31 March 2027 | Viewed by 455
Editor
Interests: mechanical ventilation; critical care medicine; weaning mechanical ventilation; non invasive ventilation
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Pulmonary hypertension is a significant disorder frequently associated with various forms of acute or chronic respiratory failure in pulmonology, cardiology, and intensive care. Many of these patients require different forms of mechanical ventilation support and are candidates for pharmacological treatments such as inhaled pulmonary vasodilators (eNO, epoprostenol) and supporting RV function with inotropes (milrinone, dobutamine) or vasopressors (norepinephrine). Despite a better understanding of its pathophysiology and new treatment options, the prognosis for these patients remains poor, especially in cases of late diagnosis. Adding to this situation is the need to determine which factors and appropriate pharmacological and ventilatory approaches are most effective.
This Special Issue proposes the analysis and description of advances in the knowledge of treatment options for patients with cardiovascular diseases who present signs compatible with pulmonary hypertension, determination of prognostic factors, monitoring options and predictive models that allow an appropriate strategy for cardiologists, pulmonologists, anesthesiologists and critical care physicians.
Dr. Antonio Matías Esquìnas
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Cardiovascular Development and Disease is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pulmonary hypertension
- mechanical ventilation
- critical care
- pharmacology
- weaning mechanical ventilation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
